LCZ696(Sacubitril + Valsartan)

Kufotokozera Kwachidule:

Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP
LCZ696(Sacubitril + Valsartan) Kulephera kwa mtima M'nyumba    


Tsatanetsatane wa Zamalonda

Zolemba Zamalonda

PRODUCT DETAIL

Kufotokozera

LCZ696 (Sacubitril/Valsartan), yopangidwa ndi Valsartan (an ARB) ndi Sacubitril (AHU377) mu 1: 1 molar ratio, ndi kalasi yoyamba, pakamwa bioavailable, ndi awiri-acting angiotensin receptor-neprilysin (ARN) inhibitor kwa hypertension. ndi kulephera kwa mtima [1] [2] [3]. LCZ696 imathandizira matenda a shuga a cardiomyopathy poletsa kutupa, kupsinjika kwa okosijeni ndi apoptosis.

 

Mbiri

LCZ696 ndi yoyamba mu kalasi ya ARNi (angiotensin receptor neprilysin inhibitor) yomwe imakhala ndi anionic moieties ya AR valsartan ndi neprilysin inhibitor prodrug AHU377 (1: 1 chiŵerengero) cha kulephera kwa mtima ndi matenda oopsa.

Ma angiotensin receptors ndi G-protein-coupled receptors. Amayimira pakati pamtima ndi zotsatira zina za angiotensin II yomwe ndi bioactive peptide ya renin-angiotensin system. Neprilysin ndi endopeptidase yopanda ndale yomwe imawononga ma peptides amkati a vasoactive monga natriuretic peptides. Kuletsa kwa neprilysin kumawonjezera kuchuluka kwa ma peptides a natriuretic omwe adathandizira kuteteza mtima, mitsempha ndi aimpso. [1]

Mu makoswe a Sprague-Dawley, kuwongolera pakamwa kwa LCZ696 kunapangitsa kuti pakhale kukwera kodalira kwa mlingo wa immunoreactivity wa peptide ya atrial natriuretic chifukwa cha kuletsa kwa neprilysin. Mu makoswe amtundu wapawiri wa transgenic, LCZ696 idayambitsa kudalira kwa mlingo komanso kuchepa kwapang'onopang'ono kwapakati. Ophunzira athanzi, kafukufuku wopangidwa mwachisawawa, wakhungu kawiri, woyendetsedwa ndi placebo adatsimikizira kuti LCZ696 idapereka inhibition ya neprilysin nthawi yomweyo ndi blockade ya AT1 receptor. LCZ696 inali yotetezeka komanso yololera bwino mwa anthu. [2] [3]

Zolozera:
McMurray JJ, Packer M, Desai AS et al. Angiotensin-neprilysin inhibition motsutsana ndi enalapril mu kulephera kwa mtima. N Engl J Med. 2014 Sep 11; 371(11): 993-1004.
Gu J, Noe A, Chandra P, Al-Fayoumi S et al. Pharmacokinetics ndi pharmacodynamics ya LCZ696, novel-acting angiotensin receptor-neprilysin inhibitor (ARNi). J Clin Pharmacol. 2010 Apr; 50(4):401-14.
Langenickel TH, Dole WP. Angiotensin receptor-neprilysin inhibition ndi LCZ696: njira yatsopano yochizira kulephera kwa mtima, Drug Discov Today: Ther Strategies (2014),

 

Kusungirako

Ufa

-20 ° C

3 zaka
 

4°C

zaka 2
Mu zosungunulira

-80 ° C

6 miyezi
 

-20 ° C

1 mwezi

Kapangidwe ka mankhwala

LCZ696(Sacubitril + Valsartan)

CERTIFICATE

2018 GMP-2
原料药GMP证书201811 (captopril,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

KUSINTHA KWA KHALIDWE

Kasamalidwe kabwino 1

Malingaliro18Ma projekiti a Quality Consistency Evaluation omwe avomereza4,ndi6mapulojekiti akuvomerezedwa.

Kasamalidwe kabwino2

Dongosolo lotsogola lapadziko lonse lapansi loyang'anira bwino layala maziko olimba pakugulitsa.

Kasamalidwe kabwino3

Kuyang'anira kwabwino kumayendera nthawi yonse ya moyo wa chinthucho kuti zitsimikizire kuti zikuyenda bwino komanso zochiritsira.

Kasamalidwe kabwino4

Gulu la Professional Regulatory Affairs limathandizira zofunikira pakufunsira ndikulembetsa.

MANAGEMENT ZOPHUNZITSA

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

German Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cpf14-1

Chipinda chowongolera cha DCS

WOTHANDIZA

Mgwirizano wapadziko lonse lapansi
Mgwirizano wapadziko lonse lapansi
Mgwirizano wapakhomo
Mgwirizano wapakhomo

  • Zam'mbuyo:
  • Ena:

  • Lembani uthenga wanu apa ndikutumiza kwa ife